5 (599) · $ 19.00 · In stock
Numerous cancer-associated deaths are owing to a lack of effective diagnostic and therapeutic approaches. Microfluidic systems for analyzing a low volume of samples offer a precise, quick, and user-friendly technique for cancer diagnosis and treatment. Microfluidic devices can detect many cancer-diagnostic factors from biological fluids and also generate appropriate nanoparticles for drug delivery. Thus, microfluidics may be valuable in the cancer field due to its high sensitivity, high throughput, and low cost. In the present article, we aim to review recent achievements in the application of microfluidic systems for the diagnosis and treatment of various cancers. Although microfluidic platforms are not yet used in the clinic, they are expected to become the main technology for cancer diagnosis and treatment. Microfluidic systems are proving to be more sensitive and accurate for the detection of cancer biomarkers and therapeutic strategies than common assays. Microfluidic lab-on-a-chip platforms have shown remarkable potential in the designing of novel procedures for cancer detection, therapy, and disease follow-up as well as the development of new drug delivery systems for cancer treatment.
Recent advances in microfluidic technologies for circulating tumor cells: enrichment, single-cell analysis, and liquid biopsy for clinical applications - Lab on a Chip (RSC Publishing)
Nanotechnology and COVID-19 diagnosis and treatment
Circulating tumour cells for early detection of clinically relevant cancer
The potential clinical benefits of ctDNA detection as a promising
Microfluidics - Wikipedia
Microfluidic systems for cancer diagnostics - ScienceDirect
Label-free microfluidic technologies for CTC detection and isolation
Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions
Micromachines, Free Full-Text